The mortality in sepsis remains very high, despite constant research and development activities by science and medical industry. The causes, in particular the malfunctions of the immune system, have not yet been able to be elucidated.
ARTCLINE would like to resolve this conflict with a new therapeutic approach.
The ARTICE® Therapy fights sepsis with immune cells from healthy donors.
The therapy uses phagocytes, so-called granulocytes. The immune cells of the donor temporarily take over the disrupted function of the patient’s own immune cells. Inflammatory substances are removed from the patient’s plasma. In addition, immunological messenger substances are produced. These substances are intended to support the regeneration of the patients’ immune system.
The extracorporeal immune cell-therapy replaces the immune cell-function and could be used as an additional therapy option in sepsis.